BCG Skin Infection Triggers IL-1R-MyD88-Dependent Migration of EpCAM CD11b Skin Dendritic cells to Draining Lymph Node During CD4+ T-Cell Priming
The arrival of bacilli in the lymph node is a bottleneck for initiating T cell responses to mycobacteria but remains poorly studied. To address this we used a mouse model to track the entry of cells and bacteria into the lymph node during skin infection with Mycobacterium bovis BCG, the live tuberculosis vaccine. We identified a population of migratory Dendritic cells that transport bacilli from the skin into the lymph node and which engage CD4+ T cells therein. The mobilization of Dendritic cells from the skin, and with these cells the transport of mycobacteria into the lymph node, was regulated by cytokines, in particular Interleukin–1. This was also dependent on MyD88, an adaptor molecule downstream of the Interleukin–1 receptor. We also found a requirement for MyD88 in driving Dendritic cells to the lymph node that was both inherent and extrinsic to the migrating cell. These findings bare consequences for our understanding of how T-cell responses are initiated during microbial challenge in the skin and hold promises for improving vaccines of low-to-modest efficacy such as BCG, which rely on such responses.
Vyšlo v časopise:
BCG Skin Infection Triggers IL-1R-MyD88-Dependent Migration of EpCAM CD11b Skin Dendritic cells to Draining Lymph Node During CD4+ T-Cell Priming. PLoS Pathog 11(10): e32767. doi:10.1371/journal.ppat.1005206
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1005206
Souhrn
The arrival of bacilli in the lymph node is a bottleneck for initiating T cell responses to mycobacteria but remains poorly studied. To address this we used a mouse model to track the entry of cells and bacteria into the lymph node during skin infection with Mycobacterium bovis BCG, the live tuberculosis vaccine. We identified a population of migratory Dendritic cells that transport bacilli from the skin into the lymph node and which engage CD4+ T cells therein. The mobilization of Dendritic cells from the skin, and with these cells the transport of mycobacteria into the lymph node, was regulated by cytokines, in particular Interleukin–1. This was also dependent on MyD88, an adaptor molecule downstream of the Interleukin–1 receptor. We also found a requirement for MyD88 in driving Dendritic cells to the lymph node that was both inherent and extrinsic to the migrating cell. These findings bare consequences for our understanding of how T-cell responses are initiated during microbial challenge in the skin and hold promises for improving vaccines of low-to-modest efficacy such as BCG, which rely on such responses.
Zdroje
1. Platt AM, Randolph GJ (2013) Dendritic cell migration through the lymphatic vasculature to lymph nodes. Adv Immunol 120: 51–68. doi: 10.1016/B978-0-12-417028-5.00002-8 24070380
2. Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140: 805–820. doi: 10.1016/j.cell.2010.01.022 20303872
3. Walsh KP, Mills KH (2013) Dendritic cells and other innate determinants of T helper cell polarisation. Trends Immunol 34: 521–530. doi: 10.1016/j.it.2013.07.006 23973621
4. WHO (2015) Tuberculosis. fact sheet 104.
5. Flynn JL, Chan J (2001) Immunology of tuberculosis. Annu Rev Immunol 19: 93–129. 11244032
6. Cooper AM (2009) Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27: 393–422. doi: 10.1146/annurev.immunol.021908.132703 19302046
7. Doherty TM, Andersen P (2005) Vaccines for tuberculosis: novel concepts and recent progress. Clin Microbiol Rev 18: 687–702. 16223953
8. Henri S, Guilliams M, Poulin LF, Tamoutounour S, Ardouin L, et al. (2010) Disentangling the complexity of the skin dendritic cell network. Immunol Cell Biol 88: 366–375. doi: 10.1038/icb.2010.34 20231850
9. Alvarez D, Vollmann EH, von Andrian UH (2008) Mechanisms and consequences of dendritic cell migration. Immunity 29: 325–342. doi: 10.1016/j.immuni.2008.08.006 18799141
10. Heuze ML, Vargas P, Chabaud M, Le Berre M, Liu YJ, et al. (2013) Migration of dendritic cells: physical principles, molecular mechanisms, and functional implications. Immunol Rev 256: 240–254. doi: 10.1111/imr.12108 24117825
11. Tamura T, Ariga H, Kinashi T, Uehara S, Kikuchi T, et al. (2004) The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model. Int Immunol 16: 1691–1699. 15477229
12. Lambrecht BN, Pauwels RA, Fazekas De St Groth B (2000) Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model. J Immunol 164: 2937–2946. 10706680
13. Henri S, Vremec D, Kamath A, Waithman J, Williams S, et al. (2001) The dendritic cell populations of mouse lymph nodes. J Immunol 167: 741–748. 11441078
14. Diacovo TG, Blasius AL, Mak TW, Cella M, Colonna M (2005) Adhesive mechanisms governing interferon-producing cell recruitment into lymph nodes. J Exp Med 202: 687–696. 16147979
15. Abadie V, Badell E, Douillard P, Ensergueix D, Leenen PJ, et al. (2005) Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. Blood 106: 1843–1850. 15886329
16. Bedoui S, Whitney PG, Waithman J, Eidsmo L, Wakim L, et al. (2009) Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol 10: 488–495. doi: 10.1038/ni.1724 19349986
17. Kumamoto Y, Linehan M, Weinstein JS, Laidlaw BJ, Craft JE, et al. (2013) CD301b+ dermal dendritic cells drive T helper 2 cell-mediated immunity. Immunity 39: 733–743. doi: 10.1016/j.immuni.2013.08.029 24076051
18. Mollah SA, Dobrin JS, Feder RE, Tse SW, Matos IG, et al. (2014) Flt3L Dependence Helps Define an Uncharacterized Subset of Murine Cutaneous Dendritic Cells. J Invest Dermatol 134: 2850–2851.
19. Ochiai S, Roediger B, Abtin A, Shklovskaya E, Fazekas de St Groth B, et al. (2014) CD326lo CD103lo CD11blo dermal dendritic cells are activated by thymic stromal lymphopoietin during contact sensitization in mice. J Immunol 193: 2504–2511. doi: 10.4049/jimmunol.1400536 25057004
20. Lee HK, Zamora M, Linehan MM, Iijima N, Gonzalez D, et al. (2009) Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV–1 infection. J Exp Med 206: 359–370. doi: 10.1084/jem.20080601 19153243
21. Feng CG, Scanga CA, Collazo-Custodio CM, Cheever AW, Hieny S, et al. (2003) Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J Immunol 171: 4758–4764. 14568952
22. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, et al. (2005) TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 202: 1715–1724. 16365150
23. von Meyenn F, Schaefer M, Weighardt H, Bauer S, Kirschning CJ, et al. (2006) Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guerin by Flt3-ligand generated dendritic cells. Immunobiology 211: 557–565. 16920494
24. Rothfuchs AG, Bafica A, Feng CG, Egen JG, Williams DL, et al. (2007) Dectin–1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells. J Immunol 179: 3463–3471. 17785780
25. Cumberbatch M, Kimber I (1992) Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology 75: 257–263. 1551688
26. Khader SA, Partida-Sanchez S, Bell G, Jelley-Gibbs DM, Swain S, et al. (2006) Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med 203: 1805–1815. 16818672
27. Robinson RT, Khader SA, Locksley RM, Lien E, Smiley ST, et al. (2008) Yersinia pestis evades TLR4-dependent induction of IL–12(p40)2 by dendritic cells and subsequent cell migration. J Immunol 181: 5560–5567. 18832714
28. Slight SR, Lin Y, Messmer M, Khader SA (2011) Francisella tularensis LVS-induced Interleukin–12 p40 cytokine production mediates dendritic cell migration through IL–12 Receptor beta1. Cytokine 55: 372–379. doi: 10.1016/j.cyto.2011.05.017 21669537
29. Martin-Fontecha A, Sebastiani S, Hopken UE, Uguccioni M, Lipp M, et al. (2003) Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 198: 615–621. 12925677
30. Tian T, Woodworth J, Skold M, Behar SM (2005) In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. J Immunol 175: 3268–3272. 16116218
31. Celli S, Day M, Muller AJ, Molina-Paris C, Lythe G, et al. (2012) How many dendritic cells are required to initiate a T-cell response? Blood 120: 3945–3948. doi: 10.1182/blood-2012-01-408260 22995897
32. Wolf AJ, Desvignes L, Linas B, Banaiee N, Tamura T, et al. (2008) Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med 205: 105–115. 18158321
33. Reiley WW, Calayag MD, Wittmer ST, Huntington JL, Pearl JE, et al. (2008) ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc Natl Acad Sci U S A 105: 10961–10966. doi: 10.1073/pnas.0801496105 18667699
34. Biot C, Rentsch CA, Gsponer JR, Birkhauser FD, Jusforgues-Saklani H, et al. (2012) Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Science translational medicine 4: 137ra172.
35. Wolf AJ, Linas B, Trevejo-Nunez GJ, Kincaid E, Tamura T, et al. (2007) Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 179: 2509–2519. 17675513
36. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, et al. (2003) Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19: 47–57. 12871638
37. Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, et al. (2006) Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25: 153–162. 16860764
38. Rothfuchs AG, Egen JG, Feng CG, Antonelli LR, Bafica A, et al. (2009) In situ IL–12/23p40 production during mycobacterial infection is sustained by CD11bhigh dendritic cells localized in tissue sites distinct from those harboring bacilli. J Immunol 182: 6915–6925. doi: 10.4049/jimmunol.0900074 19454688
39. Srivastava S, Ernst JD (2014) Cell-to-cell transfer of M. tuberculosis antigens optimizes CD4 T cell priming. Cell Host Microbe 15: 741–752. doi: 10.1016/j.chom.2014.05.007 24922576
40. Gerner MY, Torabi-Parizi P, Germain RN (2015) Strategically localized dendritic cells promote rapid T cell responses to lymph-borne particulate antigens. Immunity 42: 172–185. doi: 10.1016/j.immuni.2014.12.024 25607462
41. Igyarto BZ, Haley K, Ortner D, Bobr A, Gerami-Nejad M, et al. (2011) Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 35: 260–272. doi: 10.1016/j.immuni.2011.06.005 21782478
42. Bachy V, Hervouet C, Becker PD, Chorro L, Carlin LM, et al. (2013) Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays. Proc Natl Acad Sci U S A 110: 3041–3046. doi: 10.1073/pnas.1214449110 23386724
43. Ribeiro-Gomes FL, Peters NC, Debrabant A, Sacks DL (2012) Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-leishmania response. PLoS Pathog 8: e1002536. doi: 10.1371/journal.ppat.1002536 22359507
44. Zhao X, Deak E, Soderberg K, Linehan M, Spezzano D, et al. (2003) Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus–2. J Exp Med 197: 153–162. 12538655
45. Fremond CM, Togbe D, Doz E, Rose S, Vasseur V, et al. (2007) IL–1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J Immunol 179: 1178–1189. 17617611
46. Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, et al. (2010) Caspase–1 independent IL-1beta production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol 184: 3326–3330. doi: 10.4049/jimmunol.0904189 20200276
47. Marakalala MJ, Graham LM, Brown GD (2010) The role of Syk/CARD9-coupled C-type lectin receptors in immunity to Mycobacterium tuberculosis infections. Clin Dev Immunol 2010: 567571. doi: 10.1155/2010/567571 21274433
48. Dorhoi A, Desel C, Yeremeev V, Pradl L, Brinkmann V, et al. (2010) The adaptor molecule CARD9 is essential for tuberculosis control. J Exp Med 207: 777–792. doi: 10.1084/jem.20090067 20351059
49. Cumberbatch M, Dearman RJ, Kimber I (1997) Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin–1 beta for migration. Immunology 92: 388–395. 9486113
50. Otsuka A, Kubo M, Honda T, Egawa G, Nakajima S, et al. (2011) Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity. PLoS One 6: e25538. doi: 10.1371/journal.pone.0025538 21980488
51. Vigl B, Aebischer D, Nitschke M, Iolyeva M, Rothlin T, et al. (2011) Tissue inflammation modulates gene expression of lymphatic endothelial cells and dendritic cell migration in a stimulus-dependent manner. Blood 118: 205–215. doi: 10.1182/blood-2010-12-326447 21596851
52. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, et al. (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143–150. 9697844
53. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, et al. (1996) IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4: 471–481. 8630732
54. Vieira LQ, Goldschmidt M, Nashleanas M, Pfeffer K, Mak T, et al. (1996) Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J Immunol 157: 827–835. 8752935
55. Sorensen LN, Reinert LS, Malmgaard L, Bartholdy C, Thomsen AR, et al. (2008) TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J Immunol 181: 8604–8612. 19050280
56. Glaccum MB, Stocking KL, Charrier K, Smith JL, Willis CR, et al. (1997) Phenotypic and functional characterization of mice that lack the type I receptor for IL–1. J Immunol 159: 3364–3371. 9317135
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2015 Číslo 10
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Chronobiomics: The Biological Clock as a New Principle in Host–Microbial Interactions
- Interferon-γ: The Jekyll and Hyde of Malaria
- Crosslinking of a Peritrophic Matrix Protein Protects Gut Epithelia from Bacterial Exotoxins
- Modulation of the Surface Proteome through Multiple Ubiquitylation Pathways in African Trypanosomes